Brief: SynAct Pharma Q2 Pre-Tax Loss Narrows To SEK 5.9 Mln
Aug 28 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q2 PRE-TAX LOSS SEK 5.9 MILLION VERSUS LOSS 7.3 MILLION
YEAR AGO
Source text for Eikon: ID:nWkr4mLTQm
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026